http://www.medcleantechnologies.com/
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut.
(Click on link below to view a must see video.)
http://www.youtube.com/watch?v=GTpuKnWo2QI
http://www.medassets.com/
http://www.reuters.com/article/pressRelease/idUS119193+26-Mar-2009+PRN20090326
MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
Thu Mar 26, 2009 8:00am EDT
MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals
MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue
cycle solutions that help control cost, improve margins and cash flow,
increase regulatory compliance, and optimize operational efficiency. MedAssets
serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers.
http://finance.yahoo.com/q/pr?s=MDAS
(MedAssets Trades on the NASDAQ as MDAS at over $20.00+ per share.)
http://www.state.nj.us/dep/
MedClean Technologies, Inc. Approved in New Jersey
http://www.reuters.com/article/pressRelease/idUS141127%2B12-May-2009%2BPRN20090512
Garden State Hospitals Can Now Enjoy MedClean Guaranteed Saving Program
Approval Follows Joint Authorization Process by NJ Department of Environmental
Protection and NJ Department of Health and Senior Services
http://www.state.nj.us/dep/dshw/rrtp/aamwdt.04.htm
Part 1
http://biomedreports.com/articles/most-popular/19782-part-i-one-mans-trash-is-another-mans-treasure-medclean-technologies-otcmcln.html
Part 2
http://biomedreports.com/component/content/article/56-top-leading-news/20594-part-ii-medclean-prepared-for-more-growth.html
Efficacy
MedClean Technologies sets the standard for efficacy testing and validation through an ongoing commitment that has resulted in the most extensive body of work in the industry. The MedClean System meets and exceeds the most demanding standards throughout all 50 states. Our work in this area has yielded a protocol that includes significant proprietary intellectual property and is the subject of a United States patent. All MedClean efficacy testing and protocol development is conducted using actual RMW from healthcare institutions to mirror real world operations.
MedClean Technologies is committed to ongoing research and development in this area and to close collaboration with industry experts to provide continuous enhancement of its Best Practices.
http://www.medcleantechnologies.com/process-overview
http://www.medcleantechnologies.com/container-and-mobile-solutions
http://www.medcleantechnologies.com/fixed-and-custom-solutions
System Components
http://www.medcleantechnologies.com/system-components
Medcleantechnologies, Inc. Partnerships: http://www.medcleantechnologies.com/partners style="font-size: medium;">
http://sterilizers360.com/sterilizers/aduramed-patent-application-becomes-medclean.html
Per Yahoo & SEC Filings:
http://knobias.10kwizard.com/filing.php?param=&ipage=6972085&DSEQ=1&SEQ=&SQDESC=SECTION_BODY&exp=
http://finance.yahoo.com/q/ks?s=MCLN.OB
Outstanding Shares (OS) = 809,743,450 as of Dec 2010
Restricted Shares = 293.43
Float = 588.34M
Authorized Shares (AS) = 3.5B
Management Team
http://www.medcleantechnologies.com/management-team
Jay S. Bendis
Chairman of the Board of Directors
Mr. Bendis was appointed as Chairman of the Board of the Company effective March 31, 2011. Mr. Bendis has been President of Transfer Technology Consultants during the past 20 years specializing in transferring emerging life science product concepts from design to commercialization in both domestic and international markets. He was President and CEO of Clinical Analysis Corp., which has developed a hand-held diagnostic system for patient point-of-care testing. He was Managing Partner in the Crystal Corridor Group which worked with Kent State University's Liquid Crystal Institute in facilitating liquid crystal technology. He was Executive Vice President of American BioMedica Corp, which develops, manufacturers and markets immunoassay diagnostic test kits for the workplace, correctional and clinical markets. He was President and Co-founder of Emerging Technology Systems which is a research and development company consisting of engineers specializing in developing new medical devices. His prior management positions had been with XANAR Laser Corp, a division of Johnson & Johnson as the National Sales Manager and Sales and Marketing Manager for the IVAC Corp., a division of Eli Lilly and had sales and management experience with XEROX. He was also a member of the Edison BioTechnology Center Advisory Council for the State of Ohio and presently serves on the Board of Directors of several privately and publicly held companies.
David J. Laky
President and Chief Executive Officer
Mr. Laky was appointed to the positions of President and Chief Executive Officer of the Company effective November 9, 2009. Prior to such appointment Mr. Laky was the Company's Senior Vice President of Client Services and Technology since September 2008. Mr. Laky joined the Company from eResearch Technology, Inc. where from 2005 to 2008 he was General Manager & Vice President of eClinical Group. He served eRT as VP of Professional Services from 1999 to 2005.
Cheryl K. Sadowski Chief Financial Officer
Ms. Sadowski was appointed to the positions of Chief Financial Officer of the Company effective August 4, 2009. Prior to such appointment Ms. Sadowski was the Company's Vice-President and Controller since October 2008. From February 1994 until October 2008 she held several positions at eResearchTechnology, Inc. in Bridgewater, New Jersey, including Vice President, Business Management and Senior Director, Business Management, where she was responsible for budgeting, forecasting, financial systems and analysis for the Professional Services, Project Management, Customer Care, Research & Development, IT and Cardiac Safety Divisions. She also handled the facilities management and administration for the Bridgewater office.
.
John R. Accardi
Senior Vice President of Sales/Business Development
Mr. Accardi was named Senior Vice President of Sales/Business Development in September, 2008. Prior, he was with Oracle Corporation/Siebel Systems, where he was responsible for a $40 million line of business and led sales efforts for the financial services and insurance markets in the southeast region and, earlier, served as Senior Director of Siebel's North American Reseller Network. Previously, he served as Vice President of Worldwide Sales for Rasterex, a global provider of software and services extending the value of Auto-Cad solutions. At Rasterex, Mr. Accardi drove $15 million in first year revenue and reversed an operating loss to a profit during the same period. Previously, he served in executive management capacities at systems integrator Gary Brown & Associates and applications provider Computron Software, Inc., Ross Systems and WANG Laboratories.
MCLN Contact Info
http://finance.yahoo.com/q/pr?s=MCLN.OB
MedClean Technologies, Inc
3 Trowbridge Drive
Bethel, CT 06801
Phone: 203-798-1080
Fax: 203-798-0147
Web Site: http://www.medcleantechnologies.com/
Daily View
Weekly View
